Stock ASND ASCENDIS PHARMA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Ascendis Pharma A/S

Equities

ASND

US04351P1012

Real-time Estimate Cboe BZX
Other stock markets
 10:50:02 2024-04-19 am EDT 		5-day change 1st Jan Change
144.2 USD +2.35% Intraday chart for Ascendis Pharma A/S -1.46% +14.26%
Apr. 18 European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading MT
Apr. 02 JPMorgan Adjusts Ascendis Pharma A/S Price Target to $167 From $165, Maintains Overweight Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ASND Stock
  4. Revisions Ascendis Pharma A/S